This published report yelded promising results, but the interpretations of therapeutic role of GBP in mania was difficult because the drug was always associated to a wide range of other agents, whose dose was not mainteined uncharged during the study. The objective of our study was to asses the efficacy and safety of GBP versus VPA in adjunct of a fixed dose of neuroleptics in patients hospedalized because of an outburst of acute manic symptoms.
Alberti, G., Garini, R., Marzolini, M., Beltz, J., Felcher, A., Greco, M., et al. (1998). Gabapentin (GBP) versus Valproato (VPA) as an adjunct to neuroleptics in the treatment of acute symptoms. Intervento presentato a: Congress of European Pharmacology, Strasburg, France.
Gabapentin (GBP) versus Valproato (VPA) as an adjunct to neuroleptics in the treatment of acute symptoms
Felcher, A;
1998
Abstract
This published report yelded promising results, but the interpretations of therapeutic role of GBP in mania was difficult because the drug was always associated to a wide range of other agents, whose dose was not mainteined uncharged during the study. The objective of our study was to asses the efficacy and safety of GBP versus VPA in adjunct of a fixed dose of neuroleptics in patients hospedalized because of an outburst of acute manic symptoms.
| File | Dimensione | Formato | |
|---|---|---|---|
|
poster998G.pdf
accesso aperto
Descrizione: contenuto completo di poster presentato a convegno
Dimensione
303.05 kB
Formato
Adobe PDF
|
303.05 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
